Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 20 min ago
Peer-reviewedCC BY 4.0Nutrients

Therapeutic Potential of Tea and Its Compounds in the Central Nervous System Disorders

  • Joanna Dragan1
  • Ewa Koziorowska-Gawron2
  • Marianna Pietkiewicz3
  • Anna Pokryszko-Dragan2
  1. 1Division of Clinical Chemistry and Laboratory Haematology, Department of Medical Laboratory Diagnostics, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211a, 50-556 Wrocław, Poland
  2. 2Clinical Department of Neurology, University Centre of Neurology and Neurosurgery, Faculty of Medicine, Wroclaw Medical University, Borowska 213, 50-556 Wrocław, Poland
  3. 3Faculty of Pharmacy, Wroclaw Medical University, Borowska 211, 50-556 Wrocław, Poland
Open at sourceDOICite

Abstract

Due to increasing prevalence and burden of the central nervous system (CNS) disorders and challenges associated with their treatment, there is ongoing search for new therapeutic targets, frequently conducted in the area of natural products. Tea (derived from Camellia sinensis) contains a wide range of bioactive compounds (polyphenols, alkaloids and amino acids) which positively affect general health and function of many systems, including CNS. The aim of this narrative review was to present up-to-date evidence of beneficial effects of tea and its compounds on CNS functions and to outline the most promising perspectives for their utility in management of neurological conditions. Based on extensive literature search, the authors demonstrate biochemical properties of tea-derived substances, molecular mechanisms of their antioxidative, anti-inflammatory and cytoprotective activity, as well as pathways of their specific impact on CNS. The evidence is presented from experimental and clinical studies investigating effects of tea and its compounds on the prevention or amelioration of neurodegenerative disorders (Alzheimer’s disease, Parkinson’s disease, Huntington’s disease), multiple sclerosis, cerebrovascular disease and brain tumors. Finally, limitations and barriers to these investigations are discussed and their emerging future directions are suggested.

Related

  1. HIGH-THROUGHPUT SCREENING OF BLOOD–BRAIN BARRIER-PENETRANT COMPOUNDS IDENTIFIES THERAPEUTIC CANDIDATES FOR CENTRAL NERVOUS SYSTEM-TROPIC PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
    Manuela Eduarda FRANÇA, Jessica Oliveira DE SANTIS, Mariane Minussi BAPTISTELLA +6
    Hematology, Transfusion and Cell TherapyPeer-reviewedCC BYFull textEpidemiology & public healthDOAJ
  2. Gait characteristics in people with central nervous system disorders under dual-task experimental paradigms: a scoping review.
    Haizhe Jin, Jiahao Zhang, Xinyi Meng +3
    Frontiers in aging neurosciencePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Thioredoxin system: mechanisms and therapeutic potential in mental disorders
    Le Zhang, Xin Wang, Ningning Guo +1
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  4. Therapeutic potential of Boswellia-derived compounds in skin conditions
    Eman A. Alturki, Caroline S. Weckerle, Caroline Maake +2
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyCrossrefEurope PMC
  5. Photobiomodulation as a regulator of neuroinflammation: mechanistic insights and therapeutic potential in brain disorders
    Guillaume Blivet, Cédric Bertrand, David Brauge +2
    Frontiers in NeurologyPeer-reviewedCC BY 4.0Full textMedical imaging & radiologyCrossrefEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{dragan2026therapeutic,
  title = {{Therapeutic Potential of Tea and Its Compounds in the Central Nervous System Disorders}},
  author = {Joanna Dragan and Ewa Koziorowska-Gawron and Marianna Pietkiewicz and Anna Pokryszko-Dragan},
  journal = {Nutrients},
  year = {2026},
  month = oct,
  doi = {10.3390/nu18213512},
  url = {https://www.mdpi.com/2072-6643/18/21/3512},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Therapeutic Potential of Tea and Its Compounds in the Central Nervous System Disorders
AU  - Joanna Dragan
AU  - Ewa Koziorowska-Gawron
AU  - Marianna Pietkiewicz
AU  - Anna Pokryszko-Dragan
PY  - 2026
DA  - 2026/10/25
JO  - Nutrients
DO  - 10.3390/nu18213512
UR  - https://www.mdpi.com/2072-6643/18/21/3512
AB  - Due to increasing prevalence and burden of the central nervous system (CNS) disorders and challenges associated with their treatment, there is ongoing search for new therapeutic targets, frequently conducted in the area of natural products. Tea (derived from Camellia sinensis) contains a wide range of bioactive compounds (polyphenols, alkaloids and amino acids) which positively affect general health and function of many systems, including CNS. The aim of this narrative review was to present up-to-date evidence of beneficial effects of tea and its compounds on CNS functions and to outline the most promising perspectives for their utility in management of neurological conditions. Based on extensive literature search, the authors demonstrate biochemical properties of tea-derived substances, molecular mechanisms of their antioxidative, anti-inflammatory and cytoprotective activity, as well as pathways of their specific impact on CNS. The evidence is presented from experimental and clinical studies investigating effects of tea and its compounds on the prevention or amelioration of neurodegenerative disorders (Alzheimer’s disease, Parkinson’s disease, Huntington’s disease), multiple sclerosis, cerebrovascular disease and brain tumors. Finally, limitations and barriers to these investigations are discussed and their emerging future directions are suggested.
SN  - 2072-6643
ER  -